Sara Koe PSP Research Centre, Institute of Neurology, University College London, UK.
Brain. 2012 Apr;135(Pt 4):1141-53. doi: 10.1093/brain/aws038. Epub 2012 Mar 6.
Repetitive finger tapping is commonly used to assess bradykinesia in Parkinson's disease. The Queen Square Brain Bank diagnostic criterion of Parkinson's disease defines bradykinesia as 'slowness of initiation with progressive reduction in speed and amplitude of repetitive action'. Although progressive supranuclear palsy is considered an atypical parkinsonian syndrome, it is not known whether patients with progressive supranuclear palsy have criteria-defined bradykinesia. This study objectively assessed repetitive finger tap performance and handwriting in patients with Parkinson's disease (n = 15), progressive supranuclear palsy (n = 9) and healthy age- and gender-matched controls (n = 16). The motion of the hand and digits was recorded in 3D during 15-s repetitive index finger-to-thumb tapping trials. The main finding was hypokinesia without decrement in patients with progressive supranuclear palsy, which differed from the finger tap pattern in Parkinson's disease. Average finger separation amplitude in progressive supranuclear palsy was less than half of that in controls and Parkinson's disease (P < 0.001 in both cases). Change in tap amplitude over consecutive taps was computed by linear regression. The average amplitude slope in progressive supranuclear palsy was nearly zero (0.01°/cycle) indicating a lack of decrement, which differed from the negative slope in patients with Parkinson's disease OFF levodopa (-0.20°/cycle, P = 0.002). 'Hypokinesia', defined as <50% of control group's mean amplitude, combined with 'absence of decrement', defined as mean positive amplitude slope, were identified in 87% of finger tap trials in the progressive supranuclear palsy group and only 12% in the Parkinson's disease OFF levodopa group. In progressive supranuclear palsy, the mean amplitude was not correlated with disease duration or other clinimetric scores. In Parkinson's disease, finger tap pattern was compatible with criteria-defined bradykinesia, characterized by slowness with progressive reduction in amplitude and speed and increased variability in speed throughout the tap trial. In Parkinson's disease, smaller amplitude, slower speed and greater speed variability were all associated with a more severe Unified Parkinson's Disease Rating Scale motor score. Analyses of handwriting showed that micrographia, defined as smaller than 50% of the control group's mean script size, was present in 75% of patients with progressive supranuclear palsy and 15% of patients with Parkinson's disease (P = 0.022). Most scripts performed by patients with progressive supranuclear palsy did not exhibit decrements in script size. In conclusion, patients with progressive supranuclear palsy have a specific finger tap pattern of 'hypokinesia without decrement' and they do not have criteria-defined limb bradykinesia. Similarly, 'micrographia' and 'lack of decrement in script size' are also more common in progressive supranuclear palsy than in Parkinson's disease.
手指重复叩击常用于评估帕金森病的运动迟缓。伦敦大学神经学研究所帕金森氏症脑库诊断标准将运动迟缓定义为“起始缓慢,随着动作速度和幅度逐渐降低”。虽然进行性核上性麻痹被认为是一种非典型的帕金森综合征,但尚不清楚进行性核上性麻痹患者是否存在符合标准的运动迟缓。本研究客观评估了帕金森病患者(n=15)、进行性核上性麻痹患者(n=9)和健康年龄、性别匹配对照组(n=16)的手指叩击和书写表现。在 15 秒的重复食指对拇指叩击试验中,手部和手指的运动以 3D 形式记录。主要发现是进行性核上性麻痹患者运动迟缓但无递减,这与帕金森病的手指叩击模式不同。进行性核上性麻痹患者的平均手指分离幅度小于对照组和帕金森病患者的一半(两种情况下均 P<0.001)。通过线性回归计算连续叩击时叩击幅度的变化。进行性核上性麻痹患者的平均振幅斜率接近零(0.01°/周期),表明不存在递减,与帕金森病患者停服左旋多巴时的负斜率(-0.20°/周期,P=0.002)不同。在进行性核上性麻痹患者的手指叩击试验中,87%的试验被定义为“运动迟缓,即低于对照组平均振幅的 50%”,同时 87%的试验被定义为“无递减,即平均正斜率”,而在停服左旋多巴的帕金森病患者中,只有 12%的试验被定义为“运动迟缓,即低于对照组平均振幅的 50%”,同时 12%的试验被定义为“无递减,即平均正斜率”。在进行性核上性麻痹患者中,平均振幅与疾病持续时间或其他临床计量评分无关。在帕金森病患者中,手指叩击模式与标准定义的运动迟缓一致,其特征为随着幅度和速度的逐渐降低而变慢,以及在整个叩击试验中速度变化增加。在帕金森病患者中,较小的振幅、较慢的速度和较大的速度变化均与更严重的帕金森病统一评定量表运动评分相关。对手写分析表明,小书写症,即小于对照组平均书写尺寸的 50%,在 75%的进行性核上性麻痹患者和 15%的帕金森病患者中存在(P=0.022)。大多数进行性核上性麻痹患者的书写样本没有表现出书写尺寸的递减。总之,进行性核上性麻痹患者手指叩击的特征是“运动迟缓但无递减”,且不存在符合标准的肢体运动迟缓。同样,“小书写症”和“书写尺寸无递减”在进行性核上性麻痹患者中也比帕金森病患者更常见。